Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients.
about
Pharmaceutical policies: effects of restrictions on reimbursementIncome-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthmaImpact of medicare part D plan features on use of generic drugs.Suboptimal prescribing in older inpatients and outpatients.Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritisThe impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugsPharmaceutical cost management and access to psychotropic drugs: the U.S. contextImpact of drug policy on regional trends in ezetimibe useThe rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.From physician to consumer: the effectiveness of strategies to manage health care utilization.When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physiciansPharmacy utilization and the Medicare Modernization Act.Appeals system and its outcomes in national health insurance in Taiwan.Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting.Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs.Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics.Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.Constraints on Formulary Design Under the Affordable Care Act.Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugs.Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?Impact of NSAIDs prior authorization policy on patients' QoL.The costs of treating hypertension.Impact of Medicaid preferred drug lists on therapeutic adherence.Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?
P2860
Q24236533-71C019DA-9E51-47E6-B6F2-2C90FA6E19C6Q33956598-F23CEAEA-AF55-477B-8ED4-1247E23BF888Q34079971-407CE8D8-21DF-4A14-8003-4232D6CC522DQ34156396-EEF3B6F2-BDFA-429F-BD9F-A8F68A6E10AAQ34248283-C6EE2095-731D-4A9A-A4C1-B4AACF00D338Q34337698-62B32F7B-4BE7-4A13-B74B-2B0DAFCE35F6Q34390982-A9E75B83-4C70-4D24-A316-05C4AC53EAE1Q34462245-668036F7-8F15-40B2-828B-E8B273CCE5B1Q34617315-231F80FB-4116-41FC-A2D9-3B3A8B7A9597Q35037191-E8C43094-0A0F-47C1-95D9-247A61AB79F5Q35827439-80F8FF57-4B9A-4E9B-AB91-89EF2AE0F3CFQ36078786-1083C765-4282-494B-A27E-C512ADAEF373Q36409487-33026741-8A71-4D6E-9EAE-F9A7E80BBFAEQ36570328-06990F13-7899-484A-8FB3-370DC794C1ACQ36940819-BB0184AC-3E4E-4F3F-B67D-8A26D766C4EFQ37314038-D46B9813-1148-4D9F-B34A-B853BDFAE2D1Q37352239-49789A22-2E7B-4721-82E0-F04465121EE9Q37444777-8465CDD2-56E5-4D40-9EF7-0C11B4A41DB3Q37693536-E0F60392-869B-49D1-9F79-22865DA22D23Q38944596-0DA22984-95C3-4498-ACB2-31ED8E444B02Q39445927-B302255E-0EF2-4D9B-A1E4-801578FE819AQ43263272-E48CA1EE-B328-4D00-B82A-6E8365D6438CQ45948764-0245E4CC-FA43-42C3-B50C-BA5D08D85749Q49908600-667F2A15-72FB-4E0A-A780-1B14ACDBBDE4Q50179282-A67ACBF2-EF31-4B0E-8387-2527AE7EC4E8Q50179293-7575A655-12CD-4FB2-94E3-DE89523227B9
P2860
Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Effect of a prior-authorizatio ...... ry drugs by Medicaid patients.
@en
type
label
Effect of a prior-authorizatio ...... ry drugs by Medicaid patients.
@en
prefLabel
Effect of a prior-authorizatio ...... ry drugs by Medicaid patients.
@en
P2093
P1476
Effect of a prior-authorizatio ...... ry drugs by Medicaid patients.
@en
P2093
P304
P356
10.1056/NEJM199506153322406
P407
P577
1995-06-01T00:00:00Z